表紙
市場調查報告書

末梢血單核球(PBMC)的全球市場:各產品、用途、技術、原料、地區的競爭、預測、機會 (2025年)

Global Peripheral Blood Mononuclear Cells Market, By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 954235
出版日期 內容資訊 英文 118 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

末梢血單核球(PBMC)的全球市場:各產品、用途、技術、原料、地區的競爭、預測、機會 (2025年) Global Peripheral Blood Mononuclear Cells Market, By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年08月01日內容資訊: 英文 118 Pages
簡介

全球末梢血單核球(PBMC)市場,預計從2020年到2025年的期間中,以約9%的年複合成長率成長。PBMC,對於實施生物學及病理學相關的研究和臨床調查很重要。再加上PBMC也利用於致命的疾病,免疫學,疫苗開發等相關調查。可是,PBMC相關研究的成本高,尤其是可能成為發展中國家的技術採用的課題。

本報告提供全球末梢血單核球(PBMC)市場相關調查,各市場區隔為基礎的分析與預測,市場趨勢、競爭情形分析,主要企業簡介等資訊。

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 VOC (客戶的迴響)

第5章 全球末梢血單核球(PBMC)市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品(凍結保存或冷凍PBMC,培養或fresh PBMC,末梢血單核球分離及增生套件)
    • 各用途(免疫學,感染疾病,血液學等)
    • 各技術(密度傾斜離心分離流程,白血球分離)
    • 各原料(人,動物)
    • 各企業
    • 各地區
  • 市場魅力指數

第6章 亞太地區末梢血單核球(PBMC)市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各原料
    • 各國
  • 市場魅力指數
  • 亞太地區:各國分析
    • 中國市場的展望
    • 印度市場展望
    • 日本市場展望
    • 韓國市場展望
    • 新加坡市場展望
    • 澳洲市場展望

第7章 歐洲末梢血單核球(PBMC)市場展望

  • 市場規模與預測
  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各原料
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國市場展望
    • 德國市場展望
    • 英國市場展望
    • 義大利市場展望

第8章 北美末梢血單核球(PBMC)市場展望

  • 市場規模與預測
  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各原料
    • 各國
  • 市場魅力指數
  • 北美:各國分析
    • 美國市場的展望
    • 墨西哥市場展望
    • 加拿大市場展望

第9章 南美末梢血單核球(PBMC)市場展望

  • 市場規模與預測
  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各原料
    • 各國
  • 市場魅力指數
  • 南美:各國分析
    • 巴西市場展望
    • 阿根廷市場展望
    • 哥倫比亞市場展望

第10章 中東及非洲末梢血單核球(PBMC)市場展望

  • 市場規模與預測
  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各原料
    • 各國
  • 市場魅力指數
  • 中東、非洲:各國分析
    • 南非市場展望
    • 沙烏地阿拉伯市場展望
    • UAE市場展望

第11章 市場動態

  • 促進因素
  • 課題

第12章 市場趨勢

第13章 臨床試驗

第14章 競爭情形

  • 競爭的展望
  • 企業簡介(主要企業)
    • Astarte Biologics, LLC
    • ATZ Lab Solutions (India) Pvt. Ltd.
    • BioIVT LLC
    • BioLegend, Inc.
    • BioVision, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Applications, Inc
    • Celgene Corporation
    • Creative Bioarray
    • Dapcel, Inc.
    • HemaCare Corporation
    • iXCells Biotechnologies
    • Miltenyi Biotec GmbH
    • Merck & Co., Inc.
    • Novo Nordisk A/S
    • Precision Medicine Group, LLC.
    • Qiagen NV
    • STEMCELL Technologies Inc.
    • Thermo Fisher Scientific Inc.
    • ZenBio, Inc.

第15章 策略建議

目錄
Product Code: 4561

Title:
Global Peripheral Blood Mononuclear Cells Market, By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Infectious Disease, Hematology and Others), By Technique (Density Gradient Centrifugation Process, Leukapheresis), By Source (Human, Animals), By Region, Competition, Forecast & Opportunities, 2025.

The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 - 2025. The PBMC are crucial to carry out the biology and pathology related studies as well as in clinical research. Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology, especially in developing economies.

The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, and region. The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the highest market share as they can be used for longer durations of time if stored carefully at lower temperatures. In terms of regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region. The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures.

Major players operating in the global peripheral blood mononuclear cells market include: Astarte Biologics, Inc., ATZLabs, BioIVT, BioLegend, Inc., BioVision, Bio-Rad, Cell Applications, Inc., Celgene, Creative Bioarray, Dapcel, Inc, HemaCare, iXCells Biotechnologies, Miltenyi Biotec, Merck, Novo Nordisk, Precision Medicine, Qiagen NV, STEMCELL Technologies Inc., Thermo Fisher Scientific, ZenBio, Inc., etc.

Years considered for this report:

  • Historical Years: 2015 - 2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021 - 2025

Objective of the Study:

  • To analyze and forecast the market size of global peripheral blood mononuclear cells market.
  • To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, and region.
  • To identify drivers and challenges for global peripheral blood mononuclear cells market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market.
  • To conduct pricing analysis for global peripheral blood mononuclear cells market.
  • To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading market players across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the research organizations and companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the research organizations and companies, and presence of all major players across the globe.

TechSci Research calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Biotechnology and pharma companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to peripheral blood mononuclear cells
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product:

  • Cryopreserved or Frozen PBMC
  • Cultured or Fresh PBMC
  • Peripheral Blood Mononuclear Cell Isolation & Viability Kits

Market, By Application:

  • Immunology
  • Infectious disease
  • Hematology
  • Others

Market, By Technique:

  • Density gradient centrifugation process
  • Leukapheresis

Market, By Source:

  • Human
  • Animals

Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Australia
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
  • North America
    • United States
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle east & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Peripheral Blood Mononuclear Cells Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
    • 5.2.2. By Application (Immunology, Infectious disease, Hematology and others)
    • 5.2.3. By Technique (Density gradient centrifugation process, Leukapheresis)
    • 5.2.4. By Source (Human, Animals)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Technique
    • 6.2.4. By Source
    • 6.2.5. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Product
        • 6.4.1.2.2. By Application
        • 6.4.1.2.3. By Technique
        • 6.4.1.2.4. By Source
    • 6.4.2. India Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Product
        • 6.4.2.2.2. By Application
        • 6.4.2.2.3. By Technique
        • 6.4.2.2.4. By Source
    • 6.4.3. Japan Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Product
        • 6.4.3.2.2. By Application
        • 6.4.3.2.3. By Technique
        • 6.4.3.2.4. By Source
    • 6.4.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Product
        • 6.4.4.2.2. By Application
        • 6.4.4.2.3. By Technique
        • 6.4.4.2.4. By Source
    • 6.4.5. Singapore Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Product
        • 6.4.5.2.2. By Application
        • 6.4.5.2.3. By Technique
        • 6.4.5.2.4. By Source
    • 6.4.6. Australia Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Product
        • 6.4.6.2.2. By Application
        • 6.4.6.2.3. By Technique
        • 6.4.6.2.4. By Source

7. Europe Peripheral Blood Mononuclear Cells Market Outlook

  • 7.1. Market Size & Forecast
  • 7.2. Market Size & Forecast
    • 7.2.1. By Value
  • 7.3. Market Share & Forecast
    • 7.3.1. By Product
    • 7.3.2. By Application
    • 7.3.3. By Technique
    • 7.3.4. By Source
    • 7.3.5. By Country
  • 7.4. Market Attractiveness Index
  • 7.5. Europe: Country Analysis
    • 7.5.1. France Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.1.1. Market Size & Forecast
        • 7.5.1.1.1. By Value
      • 7.5.1.2. Market Share & Forecast
        • 7.5.1.2.1. By Product
        • 7.5.1.2.2. By Application
        • 7.5.1.2.3. By Technique
        • 7.5.1.2.4. By Source
    • 7.5.2. Germany Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.2.1. Market Size & Forecast
        • 7.5.2.1.1. By Value
      • 7.5.2.2. Market Share & Forecast
        • 7.5.2.2.1. By Product
        • 7.5.2.2.2. By Application
        • 7.5.2.2.3. By Technique
        • 7.5.2.2.4. By Source
    • 7.5.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.3.1. Market Size & Forecast
        • 7.5.3.1.1. By Value
      • 7.5.3.2. Market Share & Forecast
        • 7.5.3.2.1. By Product
        • 7.5.3.2.2. By Application
        • 7.5.3.2.3. By Technique
        • 7.5.3.2.4. By Source
    • 7.5.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.4.1. Market Size & Forecast
        • 7.5.4.1.1. By Value
      • 7.5.4.2. Market Share & Forecast
        • 7.5.4.2.1. By Product
        • 7.5.4.2.2. By Application
        • 7.5.4.2.3. By Technique
        • 7.5.4.2.4. By Source

8. North America Peripheral Blood Mononuclear Cells Market Outlook

  • 8.1. Market Size & Forecast
  • 8.2. Market Size & Forecast
    • 8.2.1. By Value
  • 8.3. Market Share & Forecast
    • 8.3.1. By Product
    • 8.3.2. By Application
    • 8.3.3. By Technique
    • 8.3.4. By Source
    • 8.3.5. By Country
  • 8.4. Market Attractiveness Index
  • 8.5. North America: Country Analysis
    • 8.5.1. United States Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.1.1. Market Size & Forecast
        • 8.5.1.1.1. By Value
      • 8.5.1.2. Market Share & Forecast
        • 8.5.1.2.1. By Product
        • 8.5.1.2.2. By Application
        • 8.5.1.2.3. By Technique
        • 8.5.1.2.4. By Source
    • 8.5.2. Mexico Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.2.1. Market Size & Forecast
        • 8.5.2.1.1. By Value
      • 8.5.2.2. Market Share & Forecast
        • 8.5.2.2.1. By Product
        • 8.5.2.2.2. By Application
        • 8.5.2.2.3. By Technique
        • 8.5.2.2.4. By Source
    • 8.5.3. Canada Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.3.1. Market Size & Forecast
        • 8.5.3.1.1. By Value
      • 8.5.3.2. Market Share & Forecast
        • 8.5.3.2.1. By Product
        • 8.5.3.2.2. By Application
        • 8.5.3.2.3. By Technique
        • 8.5.3.2.4. By Source

9. South America Peripheral Blood Mononuclear Cells Market Outlook

  • 9.1. Market Size & Forecast
  • 9.2. Market Size & Forecast
    • 9.2.1. By Value
  • 9.3. Market Share & Forecast
    • 9.3.1. By Product
    • 9.3.2. By Application
    • 9.3.3. By Technique
    • 9.3.4. By Source
    • 9.3.5. By Country
  • 9.4. Market Attractiveness Index
  • 9.5. South America: Country Analysis
    • 9.5.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.1.1. Market Size & Forecast
        • 9.5.1.1.1. By Value
      • 9.5.1.2. Market Share & Forecast
        • 9.5.1.2.1. By Product
        • 9.5.1.2.2. By Application
        • 9.5.1.2.3. By Technique
        • 9.5.1.2.4. By Source
    • 9.5.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.2.1. Market Size & Forecast
        • 9.5.2.1.1. By Value
      • 9.5.2.2. Market Share & Forecast
        • 9.5.2.2.1. By Product
        • 9.5.2.2.2. By Application
        • 9.5.2.2.3. By Technique
        • 9.5.2.2.4. By Source
    • 9.5.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.3.1. Market Size & Forecast
        • 9.5.3.1.1. By Value
      • 9.5.3.2. Market Share & Forecast
        • 9.5.3.2.1. By Product
        • 9.5.3.2.2. By Application
        • 9.5.3.2.3. By Technique
        • 9.5.3.2.4. By Source

10. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook

  • 10.1. Market Size & Forecast
  • 10.2. Market Size & Forecast
    • 10.2.1. By Value
  • 10.3. Market Share & Forecast
    • 10.3.1. By Product
    • 10.3.2. By Application
    • 10.3.3. By Technique
    • 10.3.4. By Source
    • 10.3.5. By Country
  • 10.4. Market Attractiveness Index
  • 10.5. MEA: Country Analysis
    • 10.5.1. South Africa Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.1.1. Market Size & Forecast
        • 10.5.1.1.1. By Value
      • 10.5.1.2. Market Share & Forecast
        • 10.5.1.2.1. By Product
        • 10.5.1.2.2. By Application
        • 10.5.1.2.3. By Technique
        • 10.5.1.2.4. By Source
    • 10.5.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.2.1. Market Size & Forecast
        • 10.5.2.1.1. By Value
      • 10.5.2.2. Market Share & Forecast
        • 10.5.2.2.1. By Product
        • 10.5.2.2.2. By Application
        • 10.5.2.2.3. By Technique
        • 10.5.2.2.4. By Source
    • 10.5.3. UAE Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.3.1. Market Size & Forecast
        • 10.5.3.1.1. By Value
      • 10.5.3.2. Market Share & Forecast
        • 10.5.3.2.1. By Product
        • 10.5.3.2.2. By Application
        • 10.5.3.2.3. By Technique
        • 10.5.3.2.4. By Source

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Clinical Trials

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Astarte Biologics, LLC
    • 14.2.2. ATZ Lab Solutions (India) Pvt. Ltd.
    • 14.2.3. BioIVT LLC
    • 14.2.4. BioLegend, Inc.
    • 14.2.5. BioVision, Inc.
    • 14.2.6. Bio-Rad Laboratories, Inc.
    • 14.2.7. Cell Applications, Inc
    • 14.2.8. Celgene Corporation
    • 14.2.9. Creative Bioarray
    • 14.2.10. Dapcel, Inc.
    • 14.2.11. HemaCare Corporation
    • 14.2.12. iXCells Biotechnologies
    • 14.2.13. Miltenyi Biotec GmbH
    • 14.2.14. Merck & Co., Inc.
    • 14.2.15. Novo Nordisk A/S
    • 14.2.16. Precision Medicine Group, LLC.
    • 14.2.17. Qiagen NV
    • 14.2.18. STEMCELL Technologies Inc.
    • 14.2.19. Thermo Fisher Scientific Inc.
    • 14.2.20. ZenBio, Inc.

15. Strategic Recommendation

List of Figures

  • Figure 1: Global Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global Peripheral Blood Mononuclear Cells Market Size, By Product (USD Million), 2015-2025F
  • Figure 3: Global Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 4: Global Peripheral Blood Mononuclear Cells Share, By Technique (USD Million), 2015-2025F
  • Figure 5: Global Peripheral Blood Mononuclear Cells Share, By Source (USD Million), 2015-2025F
  • Figure 6: Global Peripheral Blood Mononuclear Cells Share, By Company (USD Million), 2015-2025F
  • Figure 7: Global Peripheral Blood Mononuclear Cells Market Share, By Region (USD Million), 2015-2025F
  • Figure 9: Asia Pacific Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 10: Asia Pacific Peripheral Blood Mononuclear Cells Market Size, By Product (USD Million), 2015-2025F
  • Figure 11: Asia Pacific Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 12: Asia Pacific Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 13: Asia Pacific Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 14: Asia Pacific Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 15: Asia Pacific Peripheral Blood Mononuclear Cells Market Share, By Country (USD Million), 2015-2025F
  • Figure 16: China Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 17: China Peripheral Blood Mononuclear Cells Market Size, By Product (USD Million) , 2015-2025F
  • Figure 18: China Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million) , 2015-2025F
  • Figure 19: China Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 20: China Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 21: India Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 22: India Peripheral Blood Mononuclear Cells Market Size, By Product (USD Million), 2015-2025F
  • Figure 23: India Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 24: India Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 25: India Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million) , 2015-2025F
  • Figure 26: Australia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 27: Australia Peripheral Blood Mononuclear Cells Market Size, By Product (USD Million), 2015-2025F
  • Figure 28: Australia Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 29: Australia Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 30: Australia Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 31: Japan Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 32: Japan Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 33: Japan Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 34: Japan Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 35: Japan Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 36: South Korea Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 37: South Korea Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 38: South Korea Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 39: South Korea Peripheral Blood Mononuclear Cells Market Share, By Technique, (USD Million) 2015-2025F
  • Figure 40: South Korea Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 41: Singapore Peripheral Blood Mononuclear Cells Market Share By Value (USD Million),2015-2025F
  • Figure 42: Singapore Peripheral Blood Mononuclear Cells Market Share By Product (USD Million),2015-2025F
  • Figure 43: Singapore Peripheral Blood Mononuclear Cells Market Share By Application (USD Million),2015-2025F
  • Figure 44: Figure 41: Singapore Peripheral Blood Mononuclear Cells Market Share By Value (USD Million),2015-2025F
  • Figure 45: Singapore Peripheral Blood Mononuclear Cells Market Share By Source (USD Million),2015-2025
  • Figure 46: Europe Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 45: Europe Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 46: Europe Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 47: Europe Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 48: Europe Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 49: Europe Peripheral Blood Mononuclear Cells Market, By Country (USD Million), 2015-2025
  • Figure 50: United Kingdom Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 51: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 52: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 53: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 54: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 55: Germany Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 56: Germany Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 57: Germany Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 58: Germany Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 59: Germany Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025
  • Figure 60: France Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 61: France Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 62: France Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million) , 2015-2025F
  • Figure 63: France Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 64: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 65: Italy Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 66: Italy Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 67: Italy Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 68: Italy Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 69: Italy Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 70: North America Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 71: North America Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 72: North America Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 73: North America Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 74: North America Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 75: North America Peripheral Blood Mononuclear Cells Market Share, By Country (USD Million), 2015-2025F
  • Figure 76: United States Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 77: United States Peripheral Blood Mononuclear Cells Market Size, By Product (USD Million), 2015-2025F
  • Figure 78: United States Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 79: United Sates Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 80: Australia Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 81: Mexico Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 82: Mexico Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 83: Mexico Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 84: Mexico Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 85: Mexico Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 87: Canada Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 88: Canada Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 89: Canada Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 90: Canada Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 91: Canada Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 92: South America Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 93: South America Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 94: South America Peripheral Blood Mononuclear Cells Market Share, By Application USD Million), 2015-2025F
  • Figure 95: South America Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 96: South America Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 97: South America Peripheral Blood Mononuclear Cells Market Share, By Country (USD Million),2015-2025F
  • Figure 98: Brazil Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 99: Brazil Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 100: Brazil Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 101: Brazil Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 102: Brazil Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 103: Argentina Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 104: Argentina Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 105: Argentina Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 106: Argentina Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 107: Argentina Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 108: Colombia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 109: Colombia Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 110: Colombia Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 111: Colombia Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 112: Colombia Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 113: Middle East & Africa Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 114: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 115: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 116: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 117: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 118: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Country (USD Million), 2015-2025F
  • Figure 119: South Africa Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 120: South Africa Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 121: South Africa Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 122: South Africa Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 123: South Africa Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 124: Saudi Arabia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 125: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 126: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 127: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 128: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F
  • Figure 129: UAE Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2015-2025F
  • Figure 130: UAE Peripheral Blood Mononuclear Cells Market Share, By Product (USD Million), 2015-2025F
  • Figure 131: UAE Peripheral Blood Mononuclear Cells Market Share, By Application (USD Million), 2015-2025F
  • Figure 132: UAE Peripheral Blood Mononuclear Cells Market Share, By Technique (USD Million), 2015-2025F
  • Figure 133: UAE Peripheral Blood Mononuclear Cells Market Share, By Source (USD Million), 2015-2025F